The cost of inaction (on cancer)

SEX BASED DATA IN HEALTHCARE. DOES IT MATTER?

Crisis to Catalyst. COVID19 as a blueprint for healthcare transformation.

the true cost of the economic burden of cancer in canada

flipping the script. putting the U in value frameworks

Cancer deaths must not be a side effect of the pandemic: delays in cancer diagnosis and treatment co

when to talk to your healthcare team about biomarker testing

why precision medicine matters

colorectal cancer canada survey results on molecular profiling in canada

the importance of biomarker testing

let’s talk about biomarkers – CD19

let’s talk about biomarkers- BRCA

tumour agnostic therapies are redefining cancer care

current biomarkers in cancer

understanding targeted therapies

understanding biomarkers

understanding precision medicine

what are biomarkers

cancer in canada in 2020